Adaptimmune Therapeutics (ADAP) Fails to deliver data

Key failure to deliver metrics for Adaptimmune Therapeutics:

• Last SEC data release: 2025-03-14
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: A$0.07 M
• Last year FTD volume: A$0.07 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Adaptimmune Therapeutics (ADAP) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Adaptimmune Therapeutics (ADAP) - since 2015

Adaptimmune Therapeutics (ADAP) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Novavax NVAX	A$7.68 M	A$0.12 B	🇺🇸 USA
Enzo Biochem ENZ	A$0.1 M	A$0.14 M	🇺🇸 USA
uniQure QURE	A$2.78 M	A$6.84 M	🇳🇱 Netherlands
Exelixis EXEL	A$2.75 M	A$14.16 M	🇺🇸 USA